619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regular and Young Investigator Award Abstracts

Clinical Trial Completed

619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

	Abstract	Full	Pdf
Nov 2023	280	0	16
Dec 2023	67	0	8
Jan 2024	58	0	4
Feb 2024	40	0	3
Mar 2024	58	0	5
Apr 2024	70	0	9
May 2024	72	0	5
Jun 2024	63	0	12
Jul 2024	44	0	2
Aug 2024	58	0	3
Sep 2024	66	0	3
Oct 2024	32	0	4
Nov 2024	108	0	8
Dec 2024	64	0	9
Jan 2025	44	0	12
Feb 2025	4	0	2
Mar 2025	0	0	1
Apr 2025	0	0	7
May 2025	0	0	3
Jun 2025	1	0	3
Total	1129	0	119